BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 16154649)

  • 1. Differential effects of ovarian steroids on anxiety versus fear as measured by open field test and fear-potentiated startle.
    Hiroi R; Neumaier JF
    Behav Brain Res; 2006 Jan; 166(1):93-100. PubMed ID: 16154649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential effects of exogenous and endogenous estrogen on anxiety as measured by elevated T-maze in relation to the serotonergic system.
    Pandaranandaka J; Poonyachoti S; Kalandakanond-Thongsong S
    Behav Brain Res; 2009 Mar; 198(1):142-8. PubMed ID: 19046994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TCPL delivery system as a model for E + P replacement therapy in post-ovariectomized adult rats mimicking a postmenopausal condition.
    Cason Z; Benghuzzi H; Tucci M; England B
    Biomed Sci Instrum; 2003; 39():529-34. PubMed ID: 12724947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Different effects of subchronic doses of 17-beta estradiol in two ethologically based models of anxiety utilizing female rats.
    Koss WA; Gehlert DR; Shekhar A
    Horm Behav; 2004 Aug; 46(2):158-64. PubMed ID: 15256305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantifying fear potentiated startle using absolute versus proportional increase scoring methods: implications for the neurocircuitry of fear and anxiety.
    Walker DL; Davis M
    Psychopharmacology (Berl); 2002 Nov; 164(3):318-28. PubMed ID: 12424556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anxiolytic-like effects of kappa-opioid receptor antagonists in models of unlearned and learned fear in rats.
    Knoll AT; Meloni EG; Thomas JB; Carroll FI; Carlezon WA
    J Pharmacol Exp Ther; 2007 Dec; 323(3):838-45. PubMed ID: 17823306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estrogen and/or progesterone administered systemically or to the amygdala can have anxiety-, fear-, and pain-reducing effects in ovariectomized rats.
    Frye CA; Walf AA
    Behav Neurosci; 2004 Apr; 118(2):306-13. PubMed ID: 15113256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of buspirone and alprazolam treatment on the startle-potentiated startle response.
    Commissaris RL; Fomum EA; Leavell BJ
    Depress Anxiety; 2004; 19(3):146-51. PubMed ID: 15129416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Benzodiazepines have no effect on fear-potentiated startle in humans.
    Baas JM; Grillon C; Böcker KB; Brack AA; Morgan CA; Kenemans JL; Verbaten MN
    Psychopharmacology (Berl); 2002 May; 161(3):233-47. PubMed ID: 12021826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nitric oxide involvement in estrous cycle-dependent changes of the behavioral responses of female rats in the elevated plus-maze test.
    Sadeghipour HR; Ghasemi M; Sadeghipour H; Riazi K; Soufiabadi M; Fallahi N; Dehpour AR
    Behav Brain Res; 2007 Mar; 178(1):10-7. PubMed ID: 17207542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anxiogenic treatments do not increase fear-potentiated startle in mice.
    Risbrough VB; Geyer MA
    Biol Psychiatry; 2005 Jan; 57(1):33-43. PubMed ID: 15607298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reproductive experience alters anxiety-like behavior in the female rat.
    Byrnes EM; Bridges RS
    Horm Behav; 2006 Jun; 50(1):70-6. PubMed ID: 16524576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein synthesis and the mechanisms of lasting change in anxiety induced by severe stress.
    Adamec R; Strasser K; Blundell J; Burton P; McKay DW
    Behav Brain Res; 2006 Feb; 167(2):270-86. PubMed ID: 16256211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of the acute and chronic estrogen on anxiety in the elevated T-maze.
    Kalandakanond-Thongsong S; Daendee S; Srikiatkhachorn A
    Physiol Behav; 2012 Jan; 105(2):357-63. PubMed ID: 21907223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of sex and neonatal maternal separation on fear-potentiated and light-enhanced startle.
    de Jongh R; Geyer MA; Olivier B; Groenink L
    Behav Brain Res; 2005 Jun; 161(2):190-6. PubMed ID: 15878207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of estrogen on activity and fear-related behaviors in mice.
    Morgan MA; Pfaff DW
    Horm Behav; 2001 Dec; 40(4):472-82. PubMed ID: 11716576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rat ultrasonic vocalization in aversively motivated situations and the role of individual differences in anxiety-related behavior.
    Borta A; Wöhr M; Schwarting RK
    Behav Brain Res; 2006 Jan; 166(2):271-80. PubMed ID: 16213033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fearfulness in a large N/Nih genetically heterogeneous rat stock: differential profiles of timidity and defensive flight in males and females.
    Lopez-Aumatell R; Guitart-Masip M; Vicens-Costa E; Gimenez-Llort L; Valdar W; Johannesson M; Flint J; Tobeña A; Fernandez-Teruel A
    Behav Brain Res; 2008 Mar; 188(1):41-55. PubMed ID: 18079010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential effects of alprazolam on the baseline and fear-potentiated startle reflex in humans: a dose-response study.
    Riba J; Rodríguez-Fornells A; Urbano G; Morte A; Antonijoan R; Barbanoj MJ
    Psychopharmacology (Berl); 2001 Oct; 157(4):358-67. PubMed ID: 11605094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Favoured genetic background for testing anxiolytics in the fear-potentiated and light-enhanced startle paradigms in the rat.
    Steiner MA; Lecourt H; Rakotoariniaina A; Jenck F
    Behav Brain Res; 2011 Aug; 221(1):34-42. PubMed ID: 21354212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.